Pharmaids Pharmaceuticals Ltd
Pharmaids Pharmaceuticals Ltd (PHARMAID) last traded at ₹31.2, a market capitalisation of ₹110 crore. Over the past 52 weeks the stock has ranged between ₹25.6 and ₹66. Pharmaids Pharmaceuticals Ltd last reported results for the quarter ended Jun 2026, with sales of ₹4.12 crore and net profit of ₹1.88 crore. Pharmaids Pharmaceuticals Ltd’s annual general meeting is scheduled for 11 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Pharmaids Pharmaceuticals Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Pharmaids Pharmaceuticals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹4.12 cr, down 38.1% from ₹6.66 cr a year earlier. Net profit turned positive at ₹1.88 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 5.24 | 4.71 | 4.77 | 6.66 | 8.61 | 5.43 | 7.18 | 4.12 |
| Expenses | 7.65 | 7.6 | 8.67 | 12.03 | 13.93 | 7.94 | 7.52 | 4.87 |
| Operating profit | -2.41 | -2.89 | -3.9 | -5.37 | -5.32 | -2.51 | -0.34 | -0.75 |
| OPM % | -45.99% | -61.36% | -81.76% | -80.63% | -61.79% | -46.22% | -4.74% | -18.20% |
| Other income | 0.08 | 0 | 0.13 | 0.04 | 3.03 | -0.32 | 0.01 | 4.25 |
| Interest | 0.33 | 0.48 | 1.01 | 1.2 | 0.93 | 0.72 | 0.65 | 0.6 |
| Depreciation | 0.61 | 0.64 | 0.62 | 0.61 | 0.47 | 0.48 | 0.48 | 0.49 |
| Profit before tax | -3.27 | -4.01 | -5.4 | -7.14 | -3.69 | -4.03 | -1.46 | 2.41 |
| Tax % | -30.58% | -24.94% | -11.11% | -26.05% | -30.62% | -34.24% | -25.34% | 22.41% |
| Net profit | -2.27 | -3.01 | -4.8 | -5.27 | -2.57 | -2.65 | -1.09 | 1.88 |
| EPS (₹) | -0.55 | -0.55 | -1.12 | -1.39 | -0.71 | -0.70 | -0.51 | 0.63 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Pharmaids Pharmaceuticals Ltd annual results
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 3.94 | 0 | 15.11 | 19.45 | 27.88 | 25.34 |
| Operating profit | 0.13 | -9.89 | -12.35 | -12.75 | -13.51 | -8.92 |
| OPM % | 3.30% | — | -81.73% | -65.55% | -48.46% | -35.20% |
| Net profit | 0.15 | -7.56 | -11.85 | -13.51 | -11.57 | -4.43 |
| EPS (₹) | 0.15 | -3.52 | -2.26 | -3.06 | -3.32 | -1.29 |
TTM is the trailing twelve months to the most recent quarter.
Pharmaids Pharmaceuticals Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 19%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -50%
- TTM
- 17%
- 10 Years
- 26%
- 5 Years
- 19%
- 3 Years
- -9%
- 1 Year
- -51%
- 10 Years
- %
- 5 Years
- -21%
- 3 Years
- -19%
- Last Year
- -27%
Pharmaids Pharmaceuticals Ltd shareholding pattern
Promoters held 32.99% at Jun 2026, up from 5.14% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 5.19% | 5.22% | 5.22% | 5.14% | 32.99% | 32.99% | 32.99% | 32.99% |
| Public | 94.81% | 94.79% | 94.78% | 94.87% | 67.00% | 67.01% | 67.00% | 67.02% |
| No. of shareholders | 8,049 | 8,349 | 8,220 | 8,026 | 8,027 | 8,288 | 8,406 | 8,632 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Pharmaids Pharmaceuticals Ltd’s AGM?
Pharmaids Pharmaceuticals Ltd’s annual general meeting is scheduled for 11 Sept 2026.
- AGM37th Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Pharmaids Pharmaceuticals Ltd corporate filings
- Enclosed copies of Newspaper Advertisement published on August 19, 2026 intimating the Notice of 37th Annual General Meeting of the CompanyCompany Updatelow impact
Cruxal's analysis: Pharmaids Pharmaceuticals Ltd has published a newspaper advertisement regarding the…
Read the full analysis - Annual ReportOtherslow impact
Cruxal's analysis: Pharmaids Pharmaceuticals Ltd has filed its Annual Report for the financial year 2025-26…
Read the full analysis - Notice of 37th AGM and Annual ReportAGM/EGMlow impact
Cruxal's analysis: Pharmaids Pharmaceuticals Limited has scheduled its 37th Annual General Meeting for…
Read the full analysis - Newspaper publication of unaudited financial results (standalone & consolidated) for the quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Pharmaids Pharmaceuticals Limited has published its unaudited financial results for the…
Read the full analysis - Outcome of the Board meeting held today i.e. August 12, 2026Board Meetingmedium impact
Cruxal's analysis: Pharmaids Pharmaceuticals Limited reported a standalone net profit of 2.13 crore for the…
Read the full analysis - Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....Board Meetinglow impact
Cruxal's analysis: Pharmaids Pharmaceuticals Limited has formally intimated the BSE regarding a Board…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Pharmaids Pharmaceuticals Ltd
Cruxal reads every Pharmaids Pharmaceuticals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.